Targeting AAV Vectors to the CNS via De Novo Engineered Capsid-Receptor Interactions

被引：0
|
作者：
Huang, Qin [1 ]
Chen, Albert [2 ]
Chan, Ken Y. [1 ]
Sorensen, Hikari [1 ]
Barry, Andrew J. [1 ]
Azari, Bahar [3 ]
Beddow, Thomas [1 ]
Zheng, Qingxia [1 ]
Zhao, Binhui [1 ]
Tobey, Isabelle G. [1 ]
Eid, Fatma Elzahraa [1 ]
Chan, Alina [1 ]
Deverman, Benjamin E. [1 ]
机构：
[1] Broad Inst MIT & Harvard, Cambridge, MA USA
[2] Harvard Univ, Cambridge, MA USA
[3] Northeastern Univ, Elect & Comp Engn Dept, Boston, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
441
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [21] Improving cell-specific recombination using AAV vectors in the murine CNS by capsid and expression cassette optimization
    Kawabata, Hayato
    Konno, Ayumu
    Matsuzaki, Yasunori
    Sato, Yumika
    Kawachi, Mika
    Aoki, Ryo
    Tsutsumi, Saki
    Togai, Shota
    Kobayashi, Ryosuke
    Horii, Takuro
    Hatada, Izuho
    Hirai, Hirokazu
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [22] Systemic Elimination of De Novo Capsid Protein Synthesis from Replication Competent AAV Contamination
    Lu, Hui
    Qu, Guang
    Pu, Mingliang
    Xu, Ruian
    Xiao, Weidong
    MOLECULAR THERAPY, 2009, 17 : S177 - S177
  • [23] Tissue-specific targeting of retroviral vectors via ligand-receptor interactions
    Kasahara, N
    Dozy, AM
    Kan, YW
    ADVANCED DRUG DELIVERY REVIEWS, 1995, 17 (03) : 227 - 234
  • [24] Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors (vol 8, e62097, 2013)
    Kay, C. N.
    Ryals, R. C.
    Aslanidi, G., V
    Min, S. H.
    Ruan, Q.
    PLOS ONE, 2014, 9 (09):
  • [25] AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery
    Jackson, Cody B.
    Richard, Audrey S.
    Ojha, Amrita
    Conkright, Kimberly A.
    Trimarchi, Jeffrey M.
    Bailey, Charles C.
    Alpert, Michael D.
    Kay, Mark A.
    Farzan, Michael
    Choe, Hyeryun
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 496 - 506
  • [26] Transferrin receptor targeting by de novo sheet extension
    Sahtoe, Danny D.
    Coscia, Adrian
    Mustafaoglu, Nur
    Miller, Lauren M.
    Olal, Daniel
    Vulovic, Ivan
    Yu, Ta-Yi
    Goreshnik, Inna
    Lin, Yu-Ru
    Clark, Lars
    Busch, Florian
    Stewart, Lance
    Wysocki, Vicki H.
    Ingber, Donald E.
    Abraham, Jonathan
    Baker, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (17)
  • [27] Engineered Cell Lines Can Improve Crude Lysate Titer and Non-Empty Capsid Percentage of AAV Vectors
    Deng, June
    Jia, Nannan
    Hu, Shiliang
    Chen, Yinxing
    Walsh, Noel
    Lee, William
    Iozza, Kayla
    Drouin, Lauren
    Hebben, Matthias
    Nacht, Mariana
    Liao, Jing
    MOLECULAR THERAPY, 2024, 32 (04) : 290 - 290
  • [28] Re-Engineering Capsid-Glycan Interactions Expands the CNS Transduction Profile of AAV Serotype 4
    Murlidharan, Giridhar
    Sommerville, Laura
    Ghashghaei, Troy
    Asokan, Aravind
    MOLECULAR THERAPY, 2013, 21 : S1 - S1
  • [29] Systemic Elimination of de novo Capsid Protein Synthesis from Replication-Competent AAV Contamination in the Liver
    Lu, Hui
    Qu, Guang
    Yang, Xiao
    Xu, Ruian
    Xiao, Weidong
    HUMAN GENE THERAPY, 2011, 22 (05) : 625 - 632
  • [30] Identification of a CNS-Targeting AAV Capsid Family with NHP and Human Cross-Reactivity through Directed Evolution
    Quan, Jin
    Hung, Ka Ying
    Kashyap, Samneet
    Rouse, Emily
    Kelemen, Margaret
    Lu, Xiaodong
    Chittoda, Misha
    Sampath, Harini Dhamodaran
    Desmarais, Samantha
    Bourque, Shawn Kyle
    Utturkar, Aditya
    Gianni, Davide
    Dillon, Gregory
    Sim, Sueon
    Yu, Nam-Kyung
    Cox, Kurt
    Bajrami, Bekim
    Nhu, Anh
    Clarner, Pete
    Martino, Richard Alexander
    Meeks, Caitlin
    Tran, Jimmy
    Kumar, Amit
    Seabrook, Tania
    Henry, Kate
    Choi, Jinkuk
    Deng, Shuyun
    Cabral, Joseph
    Suh, Junghae
    Yuan, Yuan
    MOLECULAR THERAPY, 2024, 32 (04) : 482 - 482
12345